生物可吸收支架市场规模、份额及成长分析（按材料类型、应用、最终用户和地区）- 2025-2032 年产业预测

生物可吸收支架市场规模预计在 2023 年达到 17.1 亿美元，并从 2024 年的 20.4 亿美元增长到 2032 年的 85 亿美元，预测期内（2025-2032 年）的复合年增长率为 19.5%。

由于技术进步和心血管疾病发病率上升，生物可吸收支架市场正在经历强劲成长。这些临时植入旨在透过逐渐溶解，使血管自然癒合来治疗冠状动脉疾病。聚合物材料由于其高生物相容性而占据该市场的主导地位，主要用于心血管护理等多种应用。最终用户包括医院、门诊手术中心和专科诊所，这是由心臟病住院人数的增加所推动的。从地区来看，拥有先进医疗体系的北美占据最大市场占有率，其次是以研究为重点的欧洲，以及受医疗投资和人口老化推动的亚太地区。儘管存在成本和对熟练专业人员的需求等挑战，正在进行的研究表明未来市场成长前景看好。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

生物可吸收支架市场规模（依材料类型和复合年增长率） (2025-2032)

• 市场概况
• 聚合物支架
• 金属鹰架

生物可吸收支架市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 冠状动脉疾病
• 周边动脉疾病

生物可吸收支架市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 门诊手术中心
• 心导管实验室

生物可吸收支架市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• Terumo Corporation（Japan）
• Biotronik SE & Co. KG（Germany）
• REVA Medical, Inc.（USA）
• Elixir Medical Corporation（USA）
• Amaranth Medical, Inc.（USA）
• Arterial Remodeling Technologies（France）
• Meril Life Sciences Pvt. Ltd.（India）
• Kyoto Medical Planning Co., Ltd.（Japan）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• S3V Vascular Technologies（India）
• Zorion Medical（USA）
• ICON Interventional Systems（USA）
• Xenogenics Corporation（USA）
• Arterius Limited（UK）
• SMT（Sahajanand Medical Technologies）（India）
• B. Braun Melsungen AG（Germany）
• Cardionovum GmbH（Germany）

结论和建议

Bioresorbable Scaffolds Market size was valued at USD 1.71 billion in 2023 and is poised to grow from USD 2.04 billion in 2024 to USD 8.5 billion by 2032, growing at a CAGR of 19.5% during the forecast period (2025-2032).

The bioresorbable scaffolds market is experiencing robust growth propelled by technological advancements and a rising prevalence of cardiovascular diseases. These temporary implants, designed to treat coronary artery disease by gradually dissolving, allow for natural vessel healing. Dominated by polymer-based materials due to their biocompatibility, the market also addresses diverse applications, predominantly in cardiovascular treatment. End-users include hospitals, ambulatory surgical centers, and specialized clinics, driven by increased cardiac intervention admissions. Geographically, North America leads in market share, supported by advanced healthcare systems, followed by Europe with its research focus, and a growing Asia-Pacific region due to healthcare investments and an aging demographic. Despite challenges like costs and the need for skilled professionals, ongoing research suggests promising market expansion ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioresorbable Scaffolds Market Segments Analysis

Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioresorbable Scaffolds Market

The rising incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, significantly propels the growth of the bioresorbable scaffolds market. As these health issues become more prevalent, there is an increasing need for advanced therapeutic options that can effectively restore blood flow. This situation fosters a strong demand for innovative medical solutions, such as bioresorbable scaffolds, which offer unique advantages in the treatment of vascular conditions. The ability of these scaffolds to provide temporary support to blood vessels while gradually dissolving is particularly appealing to healthcare providers looking to improve patient outcomes, further driving market expansion.

Restraints in the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market is confronted with a significant obstacle due to the shortage of long-term clinical evidence. There remains a pressing need for comprehensive evaluations of the performance of bioresorbable scaffold implants in comparison to conventional stents. This lack of conclusive data on their efficacy and safety could hinder healthcare professionals from fully embracing these innovative solutions, potentially affecting adoption rates. As a result, the industry must prioritize the generation of robust clinical studies to substantiate the long-term benefits and reliability of bioresorbable scaffolds, ensuring that they can be confidently integrated into patient care practices.

Market Trends of the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market is experiencing a notable surge, primarily driven by the rising geriatric population, which necessitates enhanced healthcare solutions. As the elderly demographic becomes more predominant, their susceptibility to cardiovascular diseases escalates, creating a substantial demand for innovative treatment options. Bioresorbable scaffolds offer a compelling alternative due to their ability to support vascular structures temporarily and then dissolve, eliminating the need for additional surgical interventions. This trend indicates a shift towards patient-centric approaches in cardiology, with healthcare providers increasingly adopting biocompatible materials to improve patient outcomes and overall quality of life in an aging society.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Polymer-based Scaffolds
• Metallic Scaffolds

Global Bioresorbable Scaffolds Market Size by Application & CAGR (2025-2032)

• Market Overview
• Coronary Artery Disease
• Peripheral Artery Disease

Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

Global Bioresorbable Scaffolds Market Size & CAGR (2025-2032)

• North America (Material Type, Application, End-user)
  • US
  • Canada
• Europe (Material Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S3V Vascular Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zorion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Interventional Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenogenics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMT (Sahajanand Medical Technologies) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations